Till K J, Burthem J, Lopez A, Cawley J C
Department of Haematology, Royal Liverpool Hospital, United Kingdom.
Blood. 1996 Jul 15;88(2):479-86.
Granulocyte-macrophage colony-stimulating factor (GM-CSF) receptors (GMR) are expressed on myeloid cells throughout their maturational sequence. During myelopoiesis, GM-CSF induces the proliferation of precursors and has multiple effects on more mature cells; such effects include induction of maturation and priming for subsequent stimulation. GMR is expressed on a range of other cell types including acute leukemic blasts of myeloid and lymphoid lineage, but has been little studied on more mature lymphoid cells. Using sensitive triple-layer immunophenotypic techniques, we show here that both the alpha and beta c chains of the GMR are expressed on hairy cells (HCs) and myelomatous plasma cells (PCs), but not on chronic lymphocytic leukemia (CLL) or prolymphocytic leukemia (PLL) lymphocytes. The receptor was demonstrable on normal PCs in tonsil, but not on either activated or resting tonsillar B cells or on circulating normal B lymphocytes. The expression of the receptor is therefore stage specific, rather than a feature of activation. Perhaps, surprisingly, in view of its effects on myeloid cells, GM-CSF did not stimulate the proliferation or differentiation of HCs and did not protect them from apoptosis. However, the cytokine had a profound effect on the interaction of the HC with its environment. Thus, the cytokine caused a major cytoskeletal reorganization resulting in the inhibition of motility and loss of adhesion to cellular and matrix ligands. These studies indicate the importance of GM-CSF outside myelopoiesis and demonstrate a previously unrecognized stage specific role for the cytokine in B-cell biology. Taken together with our previous report that M-CSF enhances B-cell motility, the present findings indicate that myeloid growth factors act in concert to facilitate the controlled migration of certain B cells into and within tissues.
粒细胞-巨噬细胞集落刺激因子(GM-CSF)受体(GMR)在髓系细胞整个成熟过程中均有表达。在骨髓生成过程中,GM-CSF可诱导前体细胞增殖,并对更成熟的细胞产生多种作用;这些作用包括诱导成熟以及为后续刺激进行预激。GMR在一系列其他细胞类型上也有表达,包括髓系和淋巴系谱系的急性白血病原始细胞,但在更成熟的淋巴细胞上研究较少。利用敏感的三层免疫表型技术,我们在此表明,GMR的α链和βc链均在毛细胞(HCs)和骨髓瘤浆细胞(PCs)上表达,但在慢性淋巴细胞白血病(CLL)或幼淋巴细胞白血病(PLL)淋巴细胞上不表达。该受体在扁桃体中的正常PCs上可检测到,但在活化或静息的扁桃体B细胞或循环中的正常B淋巴细胞上均未检测到。因此,该受体的表达具有阶段特异性,而非活化的特征。也许令人惊讶的是,鉴于其对髓系细胞的作用,GM-CSF并未刺激HCs的增殖或分化,也未保护它们免于凋亡。然而,该细胞因子对HC与其周围环境的相互作用有深远影响。因此,该细胞因子引起了主要的细胞骨架重组,导致运动性受到抑制以及对细胞和基质配体的黏附丧失。这些研究表明GM-CSF在骨髓生成之外的重要性,并证明了该细胞因子在B细胞生物学中此前未被认识到的阶段特异性作用。结合我们之前关于M-CSF增强B细胞运动性的报告,目前的研究结果表明,髓系生长因子协同作用以促进某些B细胞在组织内和组织间的受控迁移。